LU82013A1 - Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation - Google Patents
Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation Download PDFInfo
- Publication number
- LU82013A1 LU82013A1 LU82013A LU82013A LU82013A1 LU 82013 A1 LU82013 A1 LU 82013A1 LU 82013 A LU82013 A LU 82013A LU 82013 A LU82013 A LU 82013A LU 82013 A1 LU82013 A1 LU 82013A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- thiazolidine
- carboxylic acid
- pharmaceutically acceptable
- pharmaceutical composition
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97172978 | 1978-12-21 | ||
| US05/971,729 US4384001A (en) | 1978-12-21 | 1978-12-21 | Treatment of tumors with thiazolidine-4-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU82013A1 true LU82013A1 (fr) | 1981-02-03 |
Family
ID=25518727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU82013A LU82013A1 (fr) | 1978-12-21 | 1979-12-19 | Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4384001A (es) |
| JP (1) | JPS55115822A (es) |
| AU (1) | AU5390579A (es) |
| BE (1) | BE880744A (es) |
| CA (1) | CA1149284A (es) |
| DE (1) | DE2951050A1 (es) |
| DK (1) | DK542979A (es) |
| ES (1) | ES8102108A1 (es) |
| FR (1) | FR2444459A1 (es) |
| GB (1) | GB2039736B (es) |
| IL (1) | IL58948A0 (es) |
| IT (1) | IT1193348B (es) |
| LU (1) | LU82013A1 (es) |
| NL (1) | NL7909199A (es) |
| SE (1) | SE7910300L (es) |
| ZA (1) | ZA796918B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE53332B1 (en) * | 1980-03-14 | 1988-10-26 | Efamol Ltd | Pharmaceutical compositions |
| JPS57128625A (en) * | 1981-01-30 | 1982-08-10 | Rikagaku Kenkyusho | Carcinostatic |
| US4335210A (en) * | 1981-02-11 | 1982-06-15 | Cornell Research Foundation | Method of producing L-cysteine |
| FR2547728B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide d thiazolidine carboxylique |
| FR2547729B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide dl thiazolidine carboxylique |
| DE3586683T2 (de) * | 1984-12-18 | 1993-04-08 | Clark Pharma Dev | Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln. |
| JPH066578B2 (ja) * | 1985-12-27 | 1994-01-26 | 三共株式会社 | チアゾリジン誘導体 |
| JPH01170063U (es) * | 1988-05-11 | 1989-11-30 | ||
| JPH0467539U (es) * | 1990-10-18 | 1992-06-16 | ||
| DK0494405T3 (da) * | 1991-01-10 | 1996-11-18 | Transcend Therapeutics Inc | Anvendelse af thiazolidin-4-carboxylatderivater til behandling af lungesygdomme |
| ES2277787B1 (es) * | 2006-01-02 | 2008-06-16 | Universidad De Cadiz | Empleo de tioprolina en tratamientos de reduccion de peso corporal. |
-
1978
- 1978-12-21 US US05/971,729 patent/US4384001A/en not_active Expired - Lifetime
-
1979
- 1979-12-12 GB GB7942753A patent/GB2039736B/en not_active Expired
- 1979-12-13 IL IL58948A patent/IL58948A0/xx unknown
- 1979-12-14 SE SE7910300A patent/SE7910300L/xx unknown
- 1979-12-17 AU AU53905/79A patent/AU5390579A/en not_active Abandoned
- 1979-12-18 IT IT28170/79A patent/IT1193348B/it active
- 1979-12-19 LU LU82013A patent/LU82013A1/fr unknown
- 1979-12-19 FR FR7931158A patent/FR2444459A1/fr active Granted
- 1979-12-19 DK DK542979A patent/DK542979A/da unknown
- 1979-12-19 BE BE0/198657A patent/BE880744A/fr not_active IP Right Cessation
- 1979-12-19 ES ES487052A patent/ES8102108A1/es not_active Expired
- 1979-12-19 CA CA000342263A patent/CA1149284A/en not_active Expired
- 1979-12-19 DE DE19792951050 patent/DE2951050A1/de not_active Withdrawn
- 1979-12-20 ZA ZA00796918A patent/ZA796918B/xx unknown
- 1979-12-20 NL NL7909199A patent/NL7909199A/nl not_active Application Discontinuation
- 1979-12-20 JP JP16495079A patent/JPS55115822A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ZA796918B (en) | 1980-11-26 |
| GB2039736A (en) | 1980-08-20 |
| CA1149284A (en) | 1983-07-05 |
| US4384001A (en) | 1983-05-17 |
| BE880744A (fr) | 1980-06-19 |
| ES487052A0 (es) | 1980-12-16 |
| AU5390579A (en) | 1980-06-26 |
| IT1193348B (it) | 1988-06-15 |
| IL58948A0 (en) | 1980-03-31 |
| IT7928170A0 (it) | 1979-12-18 |
| JPS6328045B2 (es) | 1988-06-07 |
| DK542979A (da) | 1980-06-22 |
| GB2039736B (en) | 1983-04-13 |
| FR2444459A1 (fr) | 1980-07-18 |
| NL7909199A (nl) | 1980-06-24 |
| JPS55115822A (en) | 1980-09-06 |
| ES8102108A1 (es) | 1980-12-16 |
| SE7910300L (sv) | 1980-06-22 |
| DE2951050A1 (de) | 1980-07-10 |
| FR2444459B1 (es) | 1983-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230128449A1 (en) | Silicate containing compositions and methods of treatment | |
| LU82013A1 (fr) | Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation | |
| JP2004002429A (ja) | 組成物およびその治療用途 | |
| EP0059148B1 (fr) | Le chlorure de gallium, nouveau médicament anti-cancéreux | |
| JP5086331B2 (ja) | 細菌性疾患、ウィルス性疾患、真菌症、炎症、及び疼痛の治療用組成物 | |
| EP1267881B1 (fr) | UTILISATION DE MnTBAP DANS LE TRAITEMENT D'INSUFFISANCES HEPATOCELLULAIRES | |
| FR2536995A1 (fr) | Composition pour le traitement de l'arthrite | |
| CA1277240C (fr) | Medicament modulateur de l'immunite et son procede de preparation | |
| FR3066393B1 (fr) | Principe actif constitue par un melange de composes poly-lysine et utilisation dans la prevention des avc et le traitement de la phase inflammatoire post-avc | |
| EP1061938B1 (en) | Oral compositions at low dosage of cytotoxic proteins | |
| EP4045058A1 (fr) | Utilisation de nictotinamide mononucléotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoïde et compositions correspondantes | |
| EP1967187B1 (fr) | Composition à base de rutine et de L-lysine | |
| EP0152366A2 (fr) | Compositions à usage thérapeutique comprenant des composés organo-siliciés | |
| TWI722492B (zh) | 含蓮蓬萃取物之組合物及其用於治療頭頸癌症之用途 | |
| JP2009084211A (ja) | 神経細胞賦活組成物 | |
| FR2683455A1 (fr) | Composition pour la stimulation de la synthese localisee des tissus conjonctifs. | |
| CA2027593C (fr) | Composition a activite anti-agregante plaquettaire utilisable en therapeutique | |
| WO2000024402A1 (fr) | Utilisation d'antifongiques dans le traitement des scleroses | |
| WO2021105461A1 (fr) | Utilisation de composés pour la prévention et/ou le traitement de la spondylarthrite ankylosante et compositions correspondantes | |
| FR2693208A1 (fr) | Procédé d'obtention d'une composition enzymatique d'origine végétale ainsi que composition obtenue par la mise en Óoeuvre de ce procédé. | |
| JPS61180722A (ja) | ペプチド‐および／またはアミノ酸含有治療薬 | |
| FR2857594A1 (fr) | Composition pharmaceutique pour l'administration par voie nasale de piribedil | |
| FR2684297A1 (fr) | Utilisation d'un acide amine soufre pour la preparation d'un medicament destine au traitement de l'eczema. | |
| JPWO2006132245A1 (ja) | 腫瘍増殖抑制剤 | |
| LU86020A1 (fr) | Du traitement des etats hypotrophiques |